Fingerprint
Dive into the research topics of 'Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically